BlueRock Therapeutics LP, a clinical stage cell therapy company and subsidiary of Bayer AG, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for OpCT-001, …
Research-2024
Testing senses and motor skills in midlife may help predict later cognitive impairment
When researchers test motor skills, hearing, vision and smell in people in their midlife, they are better able to identify those who may develop cognitive decline or impairment 10 years later, according to a new …